Metabolic Reprogramming in Cancer: New Frontiers for Therapeutic Intervention

A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Cell Metabolism".

Deadline for manuscript submissions: 31 July 2025 | Viewed by 12

Special Issue Editors


E-Mail Website
Guest Editor
Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA
Interests: metabolite signaling; mitochondrial metabolism

E-Mail Website
Guest Editor
Department of Oncology, Johns Hopkins University, Baltimore, MD 21287, USA
Interests: cancer metabolism; LC/MS-based metabolomics; nutrition

E-Mail Website
Guest Editor
Department of Chemical Science and Technology, Università degli Studi di Roma Tor Vergata, 1, 00133 Rome, Italy
Interests: nuclear magnetic resonance; metabolomics; bladder cancer; cardiovascular diseases; metabolism and exercise
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Cancer cells rewire metabolism to support their needs for survival, growth, and proliferation. This metabolic rewiring is now recognized as a hallmark feature of cancer cells and has unveiled promising opportunities for developing novel therapies. Despite this promise, however, the metabolic plasticity and heterogeneity in cancer cells present ongoing challenges. Cancer cells can adapt their metabolic pathways to environmental changes and therapeutic pressures, leading to treatment resistance and disease progression. As such, further exploration and understanding of the underlying mechanisms driving metabolic reprogramming in cancer is necessary.

In this Special Issue, we aim to cover the recent progress in cancer therapy by targeting cancer metabolism. We hope to pave the way for innovative and effective therapeutic strategies by addressing the complexities of metabolic plasticity and heterogeneity in cancer cells. The topics include, but are not limited to, the following: 

(i) Molecular mechanisms underlying metabolic adaptability in therapeutic resistance;

(ii) Metabolic heterogeneity in cancer;

(iii) Determination of how tumor microenvironment, such as hypoxia and nutrient availability, influence cancer metabolism;

(iv) Development of novel therapies and combination strategies to improve therapeutic efficacies and clinical outcomes.

We seek original research articles, reviews, and short communications and invite researchers, clinicians, and industry professionals to contribute their insights and findings to advance our understanding of cancer metabolism and its application in clinical practice.

Dr. Songhua Hu
Dr. Yahui Wang
Dr. Daniel Oscar Cicero
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cancer metabolism
  • metabolic reprogramming
  • metabolic plasticity
  • cancer heterogeneity
  • therapeutic resistance
  • tumor microenvironment
  • combination therapies

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop